Thus, positron emission tomography (PET) targeting the glucagon-like peptide 1 receptor (GLP-1R) has evolved as a noninvasive specific tool for the diagnosis of insulinoma (10, 11, 16). This evidence concerns the gene GLP1R and pancreatic insulinoma.